Loading insider details...
Beta
Latest Form 4 (Jun 23, 2026): Exercise/Conversion of 18,880 NVAX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 23, 2026 | NOVAVAX INC (NVAX) | Exercise/Conversion | 18,880 | n/a |
| Apr 22, 2026 | Opus Genetics, Inc. (IRD) | Grant/Award | 24,367 | n/a |
| Oct 30, 2025 | NOVAVAX INC (NVAX) | Exercise/Conversion | 3,800 | n/a |
| Jun 24, 2025 | NOVAVAX INC (NVAX) | Grant/Award | 28,326 | $181.9K |
| Jun 24, 2025 | ARDELYX, INC. (ARDX) | Grant/Award | 21,468 | n/a |
| Jun 14, 2025 | NOVAVAX INC (NVAX) | Exercise/Conversion | 10,420 | n/a |
| May 2, 2025 | Opus Genetics, Inc. (IRD) | Grant/Award | 79,504 | n/a |
| Jan 17, 2025 | ARDELYX, INC. (ARDX) | Exercise/Conversion | 100,000 | $55.0K |
| Jan 2, 2025 | NOVAVAX INC (NVAX) | Exercise/Conversion | 3,800 | n/a |
| Jun 17, 2024 | ARDELYX, INC. (ARDX) | Grant/Award | 12,204 | n/a |